Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1500 of 2026 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 11/25/16
Due: 11/25/17
Phase: N/A
Priority: Normal
Start: 09/23/20
End: 02/04/21
Due: 02/04/22
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 05/22/20
End: 01/04/23
Due: 01/04/24
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 10/26/23
End: 07/01/26
Due: 07/01/27
Phase: N/A
Priority: Normal
Start: 11/15/23
End: 07/01/26
Due: 07/01/27
Phase: N/A
Priority: Normal
Start: 07/05/17
End: 02/27/25
Due: 02/27/26
Phase: N/A
Priority: Normal
Start: 09/25/18
End: 07/20/25
Due: 07/20/26
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 05/26/13
Due: 05/26/14
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 05/31/03
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 01/11/19
End: 08/24/23
Due: 08/24/24
Phase: N/A
Priority: Normal
Start: 12/06/11
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/11/18
End: 10/23/24
Due: 10/23/25
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 03/31/14
Due: 03/31/15